Dr. Michelle McMurry-Heath Discusses Policy Solutions to Tackle Antimicrobial Resistance

Dr. Michelle McMurry-Heath, President & CEO of BIO, led a discussion about antimicrobial resistance (AMR), and possible policy solutions – such as a proposed bill called the PASTEUR Act – to tackle AMR around the globe. She spoke with two co-sponsors of the bill, U.S. Senators Todd Young (R-IN), and Sen. Michael Bennet (D-CO).

According to the Centers for Disease Control and Prevention’s (CDC) Antibiotic Resistance Threats in the United States report, more than 2.8 million antibiotic-resistant infections occur in the U.S. each year, and at least 35,000 people die as a result of these “superbugs.”

A robust pipeline of novel antimicrobial medicines is necessary for treatments to keep pace with evolving pathogens. With support from Congress, legislation can incentivize researchers to develop new antimicrobial treatments for infections for which there is an unmet medical need, anticipated clinical need, or drug resistance.

July 20, 2022
Video courtesy of Roll Call

source